H-ras mutation detection in bladder cancer by COLD-PCR analysis and direct sequencing

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer is a significant health concern globally.
• Accurate mutation detection is crucial for understanding cancer development and recurrence.
• The H-ras gene is frequently implicated in various cancers, including bladder cancer.

Purpose of the Study:

• To evaluate the efficacy of co-amplification at lower denaturation temperature-polymerase chain reaction (COLD-PCR) for detecting H-ras gene mutations in Chinese bladder cancer patients.
• To compare the mutation detection rate of COLD-PCR with conventional polymerase chain reaction (PCR).

Main Methods:

• Analysis of 86 fresh human bladder cancer tissues.
• Mutation identification in H-ras gene exons 1 and 2 using COLD-PCR and conventional PCR.
• Direct sequencing for mutation confirmation.

Main Results:

• COLD-PCR identified a high frequency of silent mutations (29.1%) in H-ras exon 1 (c.81T>C, H27H).
• Activating mutations in H-ras were detected in 8.1% of cases.
• COLD-PCR demonstrated a 36% improvement in mutation detection compared to conventional PCR.
• Silent mutations were more frequent in recurrent bladder tumors than in primary tumors (p = 0.034).

Conclusions:

• COLD-PCR is a sensitive, reliable, and convenient method for clinical mutation detection in bladder cancer.
• The method is easily adoptable without additional reagents or instruments.
• Silent mutations may represent important genomic alterations in bladder cancer and potentially contribute to tumor recurrence.